Our proteomic analysis and PRM validation confirmed that HSD17B2 and HSD17B6 were both significantly downregulated in db/db mice compared with bks mice, which could provide insights into the association between HSD17B2 or HSD17B6 and NAFLD and diabetes based on steroid metabolism. Here, HSD17B2 is linked to metabolic dysfunction-associated steatotic liver disease.